Akrivia Biosciences Private LimitedDevelopment/Validation StageAkrivia Biosciences Private LimitedInnovator in Next-Generation Precision Diagnostics for treatment planning for various types of Cancers
Akrivia Biosciences is, at heart, an innovator focusing on precise cancer diagnostics and precision medicine. With intense research work done by our founder, who has deep expertise in the field of translational cancer science, we have developed first-of-its-kind innovative multi-tier method-based cancer classification systems that would significantly improve cancer diagnostics and lead to a ‘tailored precision medicine’ approach for the patients.
Startup Description
Founded by Amit Gupta, PhD, Akrivia is at heart an innovation maker with a focus on precision medicine in cancer treatment. Akrivia, taken from the Greek word for precision, the name itself signifies our dedication to the exactness of science
Our founder has deep expertise in the field of translational cancer science and has been the lead in several significant research projects at multiple research institutes of repute, the Institute of Cancer Research, London, among them.
Product Screenshots
Business Model
Next-Generation Cancer Diagnostics products that would be classed as Standard of Care in Cancer Diagnostics. Also generate revenue from the same.
Customers
based in
India, Australia & New Zealand (Oceania)
Business
Modal Type
Maturity
Type of
Sales
B2B, B2C
Competitors
Agendia Health, Exact Sciences, Foundation Medicine, Qiagen.
Teams
Dr Amit Gupta
CEO & Founder
Pratik Kothari
CFO & Co-Founder
Dr Bhaskar Bhattacharya
COO
Tell us a bit about how founding team knows
each other.
Founders know each other since 2015 and have been housemates since 2015 in the UK.
Why did you decide to start this
company?
Cancer is a global health challenge. Any innovation that helps the world tackle this challenge would save millions of lives.
Are all the founders full-time on this
project?
Yes
Looking for an
opportunity to invest in companies
like Akrivia Biosciences Private Limited?
